Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1b Dose-Finding Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 in Patients With Advanced or Metastatic Cancer

Next Previous
Trial Profile

Phase 1b Dose-Finding Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 in Patients With Advanced or Metastatic Cancer

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Oct 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Cobolimab (Primary) ; Dostarlimab (Primary) ; Niraparib (Primary) ; Paclitaxel (Primary) ; Pemetrexed (Primary)
  • Indications Cancer; Non-small cell lung cancer; Solid tumours
  • Focus Adverse reactions
  • Acronyms IOLite
  • Sponsors GlaxoSmithKline; GSK; TESARO

Most Recent Events

  • 14 Oct 2025 Status changed from active, no longer recruiting to completed.
  • 27 May 2024 Planned End Date changed from 22 Apr 2024 to 30 Aug 2024.
  • 02 Jun 2023 Planned End Date changed from 20 Apr 2023 to 22 Apr 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top